The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

Heparin, a naturally occurring glycosaminoglycan, has been found to have antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of COVID-19. To elucidate the mechanistic basis for the antiviral activity of heparin, we investigated the binding of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Paiardi, Giulia (VerfasserIn) , Richter, Stefan (VerfasserIn) , Oreste, Pasqua (VerfasserIn) , Urbinati, Chiara (VerfasserIn) , Rusnati, Marco (VerfasserIn) , Wade, Rebecca C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: The journal of biological chemistry
Year: 2022, Jahrgang: 298, Heft: 2, Pages: 1-14
ISSN:1083-351X
DOI:10.1016/j.jbc.2021.101507
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jbc.2021.101507
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S002192582101317X
Volltext
Verfasserangaben:Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, and Rebecca C. Wade

MARC

LEADER 00000caa a2200000 c 4500
001 179741271X
003 DE-627
005 20220831080419.0
007 cr uuu---uuuuu
008 220404s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jbc.2021.101507  |2 doi 
035 |a (DE-627)179741271X 
035 |a (DE-599)KXP179741271X 
035 |a (OCoLC)1341458175 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Paiardi, Giulia  |e VerfasserIn  |0 (DE-588)1236143736  |0 (DE-627)1761324675  |4 aut 
245 1 4 |a The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms  |c Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, and Rebecca C. Wade 
264 1 |c 2022 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published, papers in press, December 18, 2021 
500 |a Gesehen am 06.04.2022 
520 |a Heparin, a naturally occurring glycosaminoglycan, has been found to have antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of COVID-19. To elucidate the mechanistic basis for the antiviral activity of heparin, we investigated the binding of heparin to the SARS-CoV-2 spike glycoprotein by means of sliding window docking, molecular dynamics simulations, and biochemical assays. Our simulations show that heparin binds at long, positively charged patches on the spike glycoprotein, thereby masking basic residues of both the receptor-binding domain (RBD) and the multifunctional S1/S2 site. Biochemical experiments corroborated the simulation results, showing that heparin inhibits the furin-mediated cleavage of spike by binding to the S1/S2 site. Our simulations showed that heparin can act on the hinge region responsible for motion of the RBD between the inactive closed and active open conformations of the spike glycoprotein. In simulations of the closed spike homotrimer, heparin binds the RBD and the N-terminal domain of two adjacent spike subunits and hinders opening. In simulations of open spike conformations, heparin induces stabilization of the hinge region and a change in RBD motion. Our results indicate that heparin can inhibit SARS-CoV-2 infection by three mechanisms: by allosterically hindering binding to the host cell receptor, by directly competing with binding to host heparan sulfate proteoglycan coreceptors, and by preventing spike cleavage by furin. Furthermore, these simulations provide insights into how host heparan sulfate proteoglycans can facilitate viral infection. Our results will aid the rational optimization of heparin derivatives for SARS-CoV-2 antiviral therapy. 
650 4 |a antiviral agent 
650 4 |a glycoprotein 
650 4 |a heparan sulfate 
650 4 |a heparin 
650 4 |a molecular dynamics 
650 4 |a SARS-CoV-2 virus spike (S) 
700 1 |a Richter, Stefan  |e VerfasserIn  |0 (DE-588)1131823915  |0 (DE-627)886575346  |0 (DE-576)488514878  |4 aut 
700 1 |a Oreste, Pasqua  |e VerfasserIn  |4 aut 
700 1 |a Urbinati, Chiara  |e VerfasserIn  |4 aut 
700 1 |a Rusnati, Marco  |e VerfasserIn  |4 aut 
700 1 |a Wade, Rebecca C.  |e VerfasserIn  |0 (DE-588)102801774X  |0 (DE-627)730136000  |0 (DE-576)276591402  |4 aut 
773 0 8 |i Enthalten in  |t The journal of biological chemistry  |d [Amsterdam] : Elsevier B.V., 1905  |g 298(2022), 2, Artikel-ID 101507, Seite 1-14  |h Online-Ressource  |w (DE-627)269247025  |w (DE-600)1474604-9  |w (DE-576)077883837  |x 1083-351X  |7 nnas  |a The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 
773 1 8 |g volume:298  |g year:2022  |g number:2  |g elocationid:101507  |g pages:1-14  |g extent:14  |a The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 
856 4 0 |u https://doi.org/10.1016/j.jbc.2021.101507  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S002192582101317X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220404 
993 |a Article 
994 |a 2022 
998 |g 102801774X  |a Wade, Rebecca C.  |m 102801774X:Wade, Rebecca C.  |d 140000  |e 140000PW102801774X  |k 0/140000/  |p 6  |y j 
998 |g 1131823915  |a Richter, Stefan  |m 1131823915:Richter, Stefan  |d 700000  |d 706000  |e 700000PR1131823915  |e 706000PR1131823915  |k 0/700000/  |k 1/700000/706000/  |p 2 
998 |g 1236143736  |a Paiardi, Giulia  |m 1236143736:Paiardi, Giulia  |d 700000  |d 706000  |e 700000PP1236143736  |e 706000PP1236143736  |k 0/700000/  |k 1/700000/706000/  |p 1  |x j 
999 |a KXP-PPN179741271X  |e 4111728057 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms","title_sort":"binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms"}],"person":[{"display":"Paiardi, Giulia","family":"Paiardi","role":"aut","given":"Giulia"},{"display":"Richter, Stefan","family":"Richter","given":"Stefan","role":"aut"},{"given":"Pasqua","role":"aut","family":"Oreste","display":"Oreste, Pasqua"},{"display":"Urbinati, Chiara","family":"Urbinati","role":"aut","given":"Chiara"},{"display":"Rusnati, Marco","family":"Rusnati","given":"Marco","role":"aut"},{"display":"Wade, Rebecca C.","role":"aut","given":"Rebecca C.","family":"Wade"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"14 S."}],"language":["eng"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"id":{"doi":["10.1016/j.jbc.2021.101507"],"eki":["179741271X"]},"recId":"179741271X","name":{"displayForm":["Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, and Rebecca C. Wade"]},"note":["Published, papers in press, December 18, 2021","Gesehen am 06.04.2022"],"relHost":[{"name":{"displayForm":["publ. by the American Society for Biochemistry and Molecular Biology"]},"recId":"269247025","disp":"The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanismsThe journal of biological chemistry","id":{"eki":["269247025"],"zdb":["1474604-9"],"issn":["1083-351X"]},"origin":[{"dateIssuedDisp":"2021-","dateIssuedKey":"2021","publisher":"Elsevier B.V. ; American Soc. of Biological Chemists ; ASBMB Publications","publisherPlace":"[Amsterdam] ; Baltimore, Md. [u.a.] ; Bethesda, Md."}],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Society for Biochemistry and Molecular Biology","role":"isb"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"journal of biological chemistry","title":"The journal of biological chemistry","subtitle":"JBC"}],"part":{"volume":"298","pages":"1-14","text":"298(2022), 2, Artikel-ID 101507, Seite 1-14","extent":"14","year":"2022","issue":"2"},"note":["Gesehen am 19.05.2021"],"titleAlt":[{"title":"JBC online"},{"title":"JBC"}],"pubHistory":["1.1905/06 -"]}]} 
SRT |a PAIARDIGIUBINDINGOFH2022